메뉴 건너뛰기




Volumn 14, Issue 6, 2007, Pages 224-226

Broad funding for oxaliplatin in Ontario (finally!)

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84867908117     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v14i6.153     Document Type: Article
Times cited : (1)

References (8)
  • 1
    • 1842569206 scopus 로고    scopus 로고
    • A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
    • Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22:23–30.
    • (2004) J Clin Oncol , vol.22 , pp. 23-30
    • Goldberg, RM1    Sargent, DJ2    Morton, RF3
  • 2
    • 0037531121 scopus 로고    scopus 로고
    • Superiority of oxaliplatin and fluorouracil–leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil–leucovorin: interim results of a phase III trial
    • Rothenberg ML, Oza AM, Bigelow RH, et al. Superiority of oxaliplatin and fluorouracil–leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil–leucovorin: interim results of a phase III trial. J Clin Oncol 2003;21:2059–69.
    • (2003) J Clin Oncol , vol.21 , pp. 2059-2069
    • Rothenberg, ML1    Oza, AM2    Bigelow, RH3
  • 3
    • 2542615200 scopus 로고    scopus 로고
    • Oxaliplatin, fluo-rouracil, and leucovorin as adjuvant treatment for colon can-cer
    • Andre T, Boni C, Mounedji–Boudiaf L, et al. Oxaliplatin, fluo-rouracil, and leucovorin as adjuvant treatment for colon can-cer. N Engl J Med 2004;350:2343–51.
    • (2004) N Engl J Med , vol.350 , pp. 2343-2351
    • Andre, T1    Boni, C2    Mounedji–Boudiaf, L3
  • 4
    • 34250210799 scopus 로고    scopus 로고
    • Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgi-cal adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07
    • Kuebler JP, Wieand HS, O’Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgi-cal adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 2007;25:2198–204.
    • (2007) J Clin Oncol , vol.25 , pp. 2198-2204
    • Kuebler, JP1    Wieand, HS2    O’Connell, MJ3
  • 5
    • 33750875793 scopus 로고    scopus 로고
    • Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first-and sec-ond-line treatment of advanced colorectal cancer
    • Jonker D, Rumble RB, Maroun J. Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first-and sec-ond-line treatment of advanced colorectal cancer. Curr Oncol 2006;13:173–84.
    • (2006) Curr Oncol , vol.13 , pp. 173-184
    • Jonker, D1    Rumble, RB2    Maroun, J.3
  • 6
    • 85127047196 scopus 로고    scopus 로고
    • Ontario, Ministry of Health and Long-Term Care. Tor-onto: Queen’s Printer for Ontario; [Available at: cited October 24, 2007]
    • Ontario, Ministry of Health and Long-Term Care. Informa-tion on the Committee to Evaluate Drugs/Cancer Care Ontario (CED/CCO) Joint Drug Review Process [Web page]. Tor-onto: Queen’s Printer for Ontario; 2006. [Available at: www.health.gov.on.ca/english/providers/pub/drugs/dqtc_cco/ dqtc_cco_mn.html; cited October 24, 2007]
    • (2006) Informa-tion on the Committee to Evaluate Drugs/Cancer Care Ontario (CED/CCO) Joint Drug Review Process [Web page]
  • 7
    • 85127033019 scopus 로고    scopus 로고
    • PrEloxatin [product monograph]. Laval, QC: Sanofi–Aventis Canada; [Available online at: cited Au-gust 23, 2007]
    • PrEloxatin [product monograph]. Laval, QC: Sanofi–Aventis Canada; 2007. [Available online at: www.sanofi-aventis.ca/products/en/eloxatin.pdf; cited Au-gust 23, 2007]
    • (2007)
  • 8
    • 85127049817 scopus 로고    scopus 로고
    • Rockville, MD: FDA; [Avail-able online at: cited November 6, 2007]
    • U.S. Food and Drug Administration (FDA). Eloxatin (oxaliplatin for injection) [product label]. Rockville, MD: FDA; 2004. [Avail-able online at: www.fda.gov/cder/foi/label/2004/ 021492s004lbl.pdf; cited November 6, 2007]
    • (2004) Eloxatin (oxaliplatin for injection) [product label]


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.